Patent & IP news for August 30, 2014

The PARADIGM-HF study; a new use for valsartan? from ipbiz.blogspot.com

What does a drug company, facing a patent expiration, do? One option is the forced switch [see IPBiz post:
CBS News on August 28 covers "forced switch" related to drug Namenda ] Another option is to ...

Share via E–mail | Twitter | Facebook

"Media corporations exist to assemble audiences for profit, not to inform the public" from ipbiz.blogspot.com

Within a post at Salon titled Fareed Zakaria’s real sins: Not plagiarism but neoliberal know-it-all-ism , one finds the text


Media corporations exist, after all, not to inform the public or help it deliberate but ...

Share via E–mail | Twitter | Facebook

CBS News covers new Novartis drug to address heart failure from ipbiz.blogspot.com

CBS Nightly News on Saturday, August 30, 2014 led off with a story on the Novartis drug LCZ696 (a combination of valsartan ( Diovan ) and sacubitril to treat heart failure), which story, including comments by Jon ...

Share via E–mail | Twitter | Facebook